Neogene Therapeutics Appoints Brent Pfeiffenberger, Pharm.D., MBA, as Chief Operating Officer

SANTA MONICA, Calif. & AMSTERDAM--(BUSINESS WIRE)--Neogene Therapeutics, Inc., a preclinical stage biotechnology company pioneering a new class of fully personalized neo-antigen T cell therapies to treat cancer, today announced the appointment of Brent Pfeiffenberger, Pharm.D., MBA, as chief operating officer. Dr. Pfeiffenberger will oversee Neogene’s business operations and will be...

Click to view original post